Company profile: Reaction Biology
1.1 - Company Overview
Company description
- Provider of assay services and protein production for early-stage drug discovery, including biochemical, biophysical, electrophysiological and cell assays for high throughput screening (HTS); kinase and epigenetic assays; recombinant and custom protein production; 2D/3D cell-based assays; in vivo pharmacology (xenograft, immuno-oncology tumor models); and ADME & safety with in vitro safety screening, cardiac safety assessment, and in vivo PK/PD studies.
Products and services
- Epigenetic Assays: HTS-optimized epigenetic assays offering methyltransferase, demethylase, and histone acetyltransferase measurements for early-stage drug discovery using robust biochemical assay technologies
- Kinase Assay Services: HTS-optimized kinase assays including panel screening, cellular assays, and customized drug discovery, leveraging robust biochemical, biophysical, electrophysiological, and cell assay technologies for early-stage drug discovery
- Protein Production: Custom-engineered protein production specializing in recombinant proteins and custom protein production services to support early-stage drug discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Reaction Biology
Aliada Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology therapies for central nervous system diseases, leveraging the MODEL platform to deliver large molecules across the blood-brain barrier via small modular protein domains. Offerings include ALIA-1758, a bispecific antibody targeting pyroglutamate amyloid beta and TfR for potentially clearing amyloid beta plaques in Alzheimer’s disease, and partner programs to develop brain-accessible therapeutics for lysosomal storage disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aliada Therapeutics company profile →
Bioassay Online
HQ: Germany
Website
- Description: Provider of creation and implementation of bioanalytical assays in pharmacology, immunology, and toxicology, offering potency assay development; GMP validation, lot release testing, and stability studies; development and execution of potency assays for biologics, proteins, monoclonal antibodies, vaccines, gene therapies, and APIs; and efficacy models and safety assessments for biosimilars or APIs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioassay Online company profile →
Clintrak
HQ: United States
Website
- Description: Provider of clinical-trial printing and labeling solutions, including design and production of single panel and booklet labels for use in clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clintrak company profile →
Invivyd
HQ: United States
Website
- Description: Provider of antibody-based therapies to protect vulnerable people from serious viral infectious diseases. Offers PEMGARDA, authorized for emergency use as pre-exposure prophylaxis against COVID-19 in certain adults and adolescents; the INVYMAB platform combining viral surveillance, predictive modeling, and antibody engineering; a pipeline of COVID-19 and influenza monoclonal antibody candidates; and clinical trials, including the CANOPY Phase 3 trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invivyd company profile →
Reverba
HQ: United States
Website
- Description: Provider of patient engagement solutions for pharmaceutical and biotechnology companies, including clinical patient engagement programs powered by the reverbaBRIDGE platform, global clinical trial optimization with patient-centered approaches and real-time data insights, expert recruitment, tech-enabled relationship management and automation, and total compliance with HIPAA, GDPR, and FDA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Reverba company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Reaction Biology
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Reaction Biology
2.2 - Growth funds investing in similar companies to Reaction Biology
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Reaction Biology
4.2 - Public trading comparable groups for Reaction Biology
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →